“FDA will not approve 19 patients phase 2 trial, it's likely we will require a phase 3 trial.”
Hi Jason
I don’t understand your logic.
Why would MSB be told a trial was un-necessary when MSB were gearing up for a trial?
Surely, there would be case for litigation if they again about-turned.?( not beyond it mind you)
MSB CC Transcript 29 Aug 24, page-19
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |